LigaSure™ F1930T Maryland Jaw Thoracic Sealer/Divider with Nano-coating

Location：Home > Our Product > Energysystem > LigaSure > LigaSure™ F1930T Maryland Jaw Thoracic Sealer/Divider with Nano-coating

LigaSure™ F1930T Maryland Jaw Thoracic Sealer/Divider with Nano-coating

COVIDIEN LigaSure™ F1930T Maryland Jaw Thoracic Sealer/Divider with Nano-coating

Phone：+86-21-54286005

Resources

LF1930T_Brochure_EN

Overview Specifications Dimensions

OVERVIEW

Reliable vessel-sealing technology

Tailored for Thoracic Surgery

The LigaSure™ Maryland jaw thoracic sealer/divider is part of our commitment to transforming lung care. 

It’s the first — and only — minimally invasive LigaSure™ device designed for VATS procedures and indicated for sealing pulmonary veins and arteries up to and including 7 mm.^1-5,⁶

The multifunctional LigaSure™ Maryland jaw thoracic device complements thoracic procedures by providing:

One-step vessel sealing⁷
Enhanced blunt dissection⁸^,⁹^,†
Secure, atraumatic grasping^8,9,†
Cold cutting independent of sealing^7,8

The LigaSure™ Technology Difference

Reliable LigaSure™ vessel-sealing technology drives the LigaSure™ thoracic device. It works by using the body’s own collagen and elastin to create a permanent seal that is designed to withstand three times normal pulmonary systolic blood pressure.³

Plus, LigaSure™ technology eliminates the guesswork — and minimizes thermal spread^8,¹⁰^,‡ — by automatically discontinuing energy delivery when the seal cycle is complete.¹¹

† 31 of 33 surgeons surveyed after use agreed. Compared to straight jaws.
‡ Based on systemic vasculature. Compared to Olympus Thunderbeat™*.
1. Based on internal report #RE00138840, LIG-45 memo, device length recommendation, thoracic (LF1930T). Feb. 6, 2018.
2. Based on internal test report #RE00125866, Jaw range burst pressure evaluation of EB4 thoracic Maryland device (LF1930T); conducted on tissue. Nov. 20–21, 2017 and Nov. 27–30, 2017.
3. Based on internal test report #RE00134865, Burst pressure verification of pulmonary veins (LF1930T). Jan. 17–18, 2018.
4. Based on internal test report #RE00122515, Verification of the LigaSure™ LF1930T device in a GLP chronic hemostasis canine study on pulmonary vasculature. Jan. 8–10, 2018.
5. Based on internal test report #RE00128442, GLP Acute pulmonary vasculature hemostasis verification study of the LF1930T in hounds. Dec. 8, 2017.
6. Based on internal report #RE00147462, Pulmonary sealing claims for the LigaSure™ LF1930T device (memo). March 29, 2018.
7. LigaSure™ Maryland jaw thoracic sealer/divider one-step sealing, nano-coated [instructions for use]. Boulder, CO: Medtronic; 2018.
8. Based on internal test report #RE00140529 rev A, LigaSure™ Maryland device, nano-coated (LF19XX) tissue testing (memo). March 5, 2018.
9. Based on internal test report #R0035742, Maryland validation, Houston and Los Angeles: independent surgeon feedback collected during porcine labs. April 16–18 and April 30–May 3, 2013.
10. Based on internal report # R0047634_A, Comparison of various competitor devices versus the Sonicision™ device and LigaSure™ LF1637 and LF1737 devices; acute porcine study. Nov. 11 and 18, 2013, and Dec. 9, 2013.
11. Based on internal test report #RE00025819 rev A, LigaSure™ device data sources for VLFT10 white papers. September 2015.